Evidence map›Paper›PMID 39836703›Full record

ArticlePLoS neglected tropical diseases2025

Incompatible Aedes aegypti male releases as an intervention to reduce mosquito population-A field trial in Puerto Rico.

Liliana Sánchez-González, Jacob E Crawford, Laura E Adams, Grayson Brown, Kyle R Ryff, Mark Delorey, Jose Ruiz-Valcarcel, Nicole Nazario, Nexilianne Borrero, Julieanne Miranda and 10 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Strategies for controllingCaribbean journal of science · 2026
    Article
  4. The inhibition mechanism ofFrontiers in microbiology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Liliana Sánchez-GonzálezDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.ORCID 0000-0001-8289-8587
Jacob E CrawfordVerily Life Sciences, San Francisco, California, United States of America.
Laura E AdamsDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Grayson BrownPuerto Rico Vector Control Unit, San Juan, Puerto Rico.
Kyle R RyffDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Mark DeloreyDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Jose Ruiz-ValcarcelDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Nicole NazarioPuerto Rico Vector Control Unit, San Juan, Puerto Rico.
Nexilianne BorreroPuerto Rico Vector Control Unit, San Juan, Puerto Rico.
Julieanne MirandaPuerto Rico Vector Control Unit, San Juan, Puerto Rico.
Sara N MitchellVerily Life Sciences, San Francisco, California, United States of America.
Paul I HowellVerily Life Sciences, San Francisco, California, United States of America.
Johanna R OhmVerily Life Sciences, San Francisco, California, United States of America.
Charlie BehlingVerily Life Sciences, San Francisco, California, United States of America.
Brian WassonVerily Life Sciences, San Francisco, California, United States of America.
Craig EldershawVerily Life Sciences, San Francisco, California, United States of America.
Bradley J WhiteVerily Life Sciences, San Francisco, California, United States of America.
Vanessa Rivera-AmillPonce Health Sciences University/Ponce Research Institute, Ponce, Puerto Rico.
Roberto BarreraDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Gabriela Paz-BaileyDivision of Vector Borne Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.

Funding

NCEZID CDC HHS U01 CK000580
6 · The paper itself

Abstract

Mosquito-transmitted viruses such as dengue are a global and growing public health challenge. Without widely available vaccines, mosquito control is the primary tool for fighting the spread of these viruses. New mosquito control technologies are needed to complement existing methods, given current challenges with scalability, acceptability, and effectiveness. A field trial was conducted in collaboration with the Communities Organized to Prevent Arboviruses project in Ponce, Puerto Rico, to measure entomological and epidemiological effects of reducing Aedes aegypti populations using Wolbachia incompatible insect technique. We packed and shipped Wolbachia-males from California and released them into 19 treatment clusters from September 2020 to December 2020. Preliminary evaluation revealed sub-optimal Wolbachia-male densities and impact on the wild-type population. In 2021, we shifted to a phased release strategy starting in four clusters, reducing the mosquito population by 49% (CI 29-63%). We describe the investigation into male quality and other factors that may have limited the impact of Wolbachia-male releases. Laboratory assays showed a small but significant impact of packing and shipping on male fitness. However, mark-release-recapture assessments suggest that male daily survival rates in the field may have been significantly impacted. We compared induced-sterility levels and suppression of the wild population and found patterns consistent with mosquito population compensation in response to our intervention. Analysis of epidemiological impact was not possible due to very low viral transmission rates during the intervention period. Our entomological impact data provide evidence that Wolbachia incompatible-male releases reduced Ae. aegypti populations, although efficacy will be maximized when releases are part of an integrated control program. With improvement of shipping vessels and shipped male fitness, packing and shipping male mosquitoes could provide a key solution for expanding access to this technology. Our project underscores the challenges involved in large and complex field effectiveness assessments of novel vector control methods.

Indexed as

AedesMosquito ControlMosquito VectorsPest Control, BiologicalWolbachiaAnimalsFemaleMalePuerto Rico

Identifiers

PMID39836703
PMCPMC11785262

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.